- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bal Pharma Ltd (BALP)
Bal Pharma Ltd stock price live, this page displays NSE BALP stock exchange data. View the BALP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bal Pharma Ltd real time stock price chart below.
What Is the Bal Pharma Ltd Stock Price Today?
The Bal Pharma Ltd stock price today is 97.52.
What Is the Stock Symbol for Bal Pharma Ltd?
The stock symbol for Bal Pharma Ltd is "BALP."
What Stock Exchange Does Bal Pharma Ltd Trade On?
Bal Pharma Ltd is listed and trades on the NSE stock exchange.
Is Bal Pharma Ltd a Good Stock to Buy?
Determining whether Bal Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BALP quote. (ISIN: INE083D01012)
What Is the Bal Pharma Ltd Stock Price Today?
The Bal Pharma Ltd stock price today is 97.52.
What Is the Stock Symbol for Bal Pharma Ltd?
The stock symbol for Bal Pharma Ltd is "BALP."
What Stock Exchange Does Bal Pharma Ltd Trade On?
Bal Pharma Ltd is listed and trades on the NSE stock exchange.
Is Bal Pharma Ltd a Good Stock to Buy?
Determining whether Bal Pharma Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BALP quote. (ISIN: INE083D01012)
97.52
+0.77(+0.80%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
95.91
98.74
52 wk Range
78.06
157.98
BALP Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
BALP is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
95.9198.74
52 wk Range
78.06157.98
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.23%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.23%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BALP Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Bal Pharma Ltd Company Profile
Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, and women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti-convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, and acne treatment, etc.; and various formulations, including tablets, capsules, syrups, suspensions, ophthalmic, creams, and ointments. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. The company exports its products to approximately 30 countries. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.
Compare BALP to Peers and Sector
Metrics to compare | BALP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBALPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.1x | 35.4x | −0.5x | |
PEG Ratio | 0.14 | 0.79 | 0.00 | |
Price/Book | 2.2x | 5.4x | 2.6x | |
Price / LTM Sales | 0.5x | 4.9x | 2.9x | |
Upside (Analyst Target) | - | 19.0% | 49.4% | |
Fair Value Upside | Unlock | −5.1% | 8.2% | Unlock |
Earnings
Latest Release
Nov 14, 2024
EPS / Forecast
0.65 / --
Revenue / Forecast
736.94M / --
FAQ
What Is the Bal Pharma Ltd (BALP) Stock Price Today?
The Bal Pharma Ltd stock price today is 97.52.
What Stock Exchange Does Bal Pharma Ltd Trade On?
Bal Pharma Ltd is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Bal Pharma Ltd?
The stock symbol for Bal Pharma Ltd is "BALP."
Does Bal Pharma Ltd Pay Dividends? What’s The Current Dividend Yield?
The Bal Pharma Ltd dividend yield is 1.23%.
What Is the Bal Pharma Ltd Market Cap?
As of today, Bal Pharma Ltd market cap is 1.54B.
What Is Bal Pharma Ltd's Earnings Per Share (TTM)?
The Bal Pharma Ltd EPS (TTM) is 4.74.
From a Technical Analysis Perspective, Is BALP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.